Dr. Hirva Mamdani, MD
Claim this profileKarmanos Cancer Institute
Expert in Lung Cancer
Studies Non-Small Cell Lung Cancer
20 reported clinical trials
29 drugs studied
Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
ALK positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
NFE2L2
Affiliated Hospitals
Clinical Trials Hirva Mamdani, MD is currently running
Chiauranib
for Advanced Cancers
This trial is testing a new drug called chiauranib for patients with advanced cancers that don't respond to standard treatments. It aims to block the signals that cancer cells need to grow. The focus is on patients with small cell lung cancer that has worsened after previous treatments.
Recruiting1 award Phase 1 & 28 criteria
Monalizumab + Durvalumab + Chemotherapy
for Small Cell Lung Cancer
This trial tests a combination of chemotherapy and immune-boosting drugs in cancer patients who have already received some treatment. The chemotherapy attacks cancer cells directly, while the immune-boosting drugs help the body’s defense system fight the cancer.
Recruiting1 award Phase 212 criteria
More about Hirva Mamdani, MD
Clinical Trial Related5 years of experience running clinical trials · Led 20 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Hirva Mamdani, MD has experience with
- Pembrolizumab
- Nivolumab
- GT103
- Atezolizumab
- SGN-EGFRd2
- Comprehensive Genomic Analysis
Breakdown of trials Hirva Mamdani, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hirva Mamdani, MD specialize in?
Hirva Mamdani, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Hirva Mamdani, MD currently recruiting for clinical trials?
Yes, Hirva Mamdani, MD is currently recruiting for 8 clinical trials in Detroit Michigan. If you're interested in participating, you should apply.
Are there any treatments that Hirva Mamdani, MD has studied deeply?
Yes, Hirva Mamdani, MD has studied treatments such as Pembrolizumab, Nivolumab, GT103.
What is the best way to schedule an appointment with Hirva Mamdani, MD?
Apply for one of the trials that Hirva Mamdani, MD is conducting.
What is the office address of Hirva Mamdani, MD?
The office of Hirva Mamdani, MD is located at: Karmanos Cancer Institute, Detroit, Michigan 48201 United States. This is the address for their practice at the Karmanos Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.